CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
87 hedge funds and large institutions have $48.3M invested in CureVac in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 19 closing their positions.
65% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
1.49% less ownership
Funds ownership: 7.83% → 6.34% (-1.5%)
3% less funds holding
Funds holding: 90 → 87 (-3)
12% less capital invested
Capital invested by funds: $55M → $48.3M (-$6.71M)
58% less call options, than puts
Call options by funds: $839K | Put options by funds: $2.01M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.92M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$989K |
| 3 |
BlackRock
New York
|
+$912K |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$598K |
| 5 |
Walleye Capital
New York
|
+$579K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$5.96M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$3.92M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.35M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.93M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$1.9M |
CVAC Hedge Fund Activity: Q2 2024 in Review
87 of the 6,934 institutional investors tracked by Wall St. Rank reported a position in CureVac (CVAC) for Q2 2024, worth a combined $48.3M — down 12% from $55M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CVAC and 18 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 33 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $7.92M. The largest seller was RA Capital Management, exiting entirely with an estimated $5.96M sold.
- 87 institutional investors held CureVac (CVAC) as of Q2 2024, down from 90 in Q1 2024.
- Funds reported $48.3M of CureVac stock for Q2 2024, down 12% quarter-over-quarter.
- 18 funds opened new CureVac positions in Q2 2024 and 19 closed out, a net change of -1 holder.
- The largest CureVac buyer in Q2 2024 was Point72 Asset Management, an estimated $7.92M added.
- The largest CureVac seller in Q2 2024 was RA Capital Management, an estimated $5.96M sold.
Based on aggregated 13F filings for Q2 2024.